The Psychopharmacology Of The FTX Crash

Must not blog about FTX . . . must not blog about . . . ah, $#@% it

Tyler Cowen linked Milky Eggs’ excellent overview of the FTX crash. I’m unqualified to comment on any of the financial or regulatory aspects. But it turns out there’s a psychopharmacology angle, which I am qualified to talk about, so let’s go. I wrote this pretty rushed because it’s an evolving news story. Sorry if it’s less polished than usual.1 Probably yes, and maybe it could have had some small effect, but probably not as much as the people discussing it on Twitter think. Milky Eggs reports a claim by an employee that Sam was on “a patch for designer stimulants that mainlined them…

saved by

• Eli Qian
• Shivam Siddaiya
• John Rho

related reading

• The Degradation Drug - The American Scholartheamericanscholar.org
• Slate Star Codexslatestarcodex.com
• The Degradation Drug - The American Scholartheamericanscholar.org
• Club Med | Broadcastpioneerworks.org
• The Good Drug Guide : new mood-brighteners and antidepressantsbiopsychiatry.com
• Adderall Risks: Much More Than You Wanted To Know | Slate Star Codexslatestarcodex.com
• A rationalist's guide to psychoactive drugs — LessWronglesswrong.com
• Monoamine Oxidase Inhibitors (MAOIs) - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• List of Fictional Drugs Banned By The FDAslatestarcodex.com
• Atomoxetine: a novel treatment for child and adult ADHD - PMCpmc.ncbi.nlm.nih.gov
• A New, Cheaper Form of Meth Is Wreaking Havoc on America - The Atlantictheatlantic.com
• Dopamine affects how brain decides whether a goal is worth the effort | National Institutes of Health (NIH)nih.gov